6 chapters across the catalog
The Lumber Yard Podcast, Rural Community Building
A couple from Seneca, Illinois, who revitalized a historic lumber yard, seeks advice on starting a local podcast. The "Podfather" provides three golden rules: keep it short, maintain a consistent schedule, and write a newsletter. He emphasizes focusing on the local community rather than trying to emulate large-scale shows like Joe Rogan's.
California Cap-and-Trade and Green Lumber Mandates
California legislators are debating changes to the state's cap-and-trade program as residents face rising utility bills and insurance premiums due to climate-related disasters. Additionally, new mandates requiring the use of "green lumber" in construction are criticized for being impractical and potentially dangerous.
Supply Chain Glitches and Lumber Price Drops
The global supply chain continues to face "container dislocation" and glitches in freight load boards. While lumber prices have dropped 40% from their peak, other sectors like microchips and Wi-Fi modules are seeing massive price hikes due to hoarding. The situation is compared to the 2011 Thailand floods that caused a similar spike in hard drive prices.
Industrial Packaging, Lumber and Plastic Film Shortages
Producers report that shortages of certified pest-free treated lumber and high-quality plastic shrink film are hindering the shipping and packaging industries. Much of the inexpensive packaging material sourced from China is reportedly of inferior quality, leading to mechanical failures in industrial machinery.
Listeners report extreme bidding wars in the Austin housing market, with homes selling for 80% more than their 2019 prices. The hosts propose a "legislative arm" for the show to draft boilerplate laws preventing institutional investors from buying up residential neighborhoods.
Real Estate Supply Issues, Ivermectin and Emergency Use Authorization
The U.S. housing market is facing severe supply chain disruptions, with lumber and pressed wood prices skyrocketing due to reported issues with Chinese imports. In the medical field, a legal argument suggests that the FDA cannot legally maintain "Emergency Use Authorization" for vaccines if effective treatments like Ivermectin or Hydroxychloroquine are available. This has led to a perceived suppression of treatment data to protect the legal status of the vaccine rollout.
